Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding Trial. PLoS Med, 13 (10), pp. e1002139. Article
ReliableGenome: annotation of genomic regions with high/low variant calling concordance. Bioinformatics. Article
Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01B With Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAP. J Infect Dis, 214 (5), pp. 772-781. Article
Tensor decomposition for multiple-tissue gene expression experiments. Nat Genet, 48 (9), pp. 1094-1100. Article
Perioperative Rosuvastatin in Cardiac Surgery. N Engl J Med, 375 (9), pp. 903. ArticleMore publications
Wellcome has announced funding of £118 million to 14 major research centres, including three centres based in Oxford. The Wellcome Centre for Human Genetics, based in Oxford for 22 years, has played a pioneering role in the progress and success of human disease genetics and mechanism research. It will continue to exploit human genetics and uncover disease biology, improving human healthcare through the development of more precise diagnostic tests and preventative or therapeutic interventions.
Scientists from the Wellcome Trust Centre for Human Genetics (WTCHG) have used Oxford Nanopore Technologies MinION sequencing devices to sequence two human DNA samples, in an exploration of the capabilities of the pocket-sized, USB-powered sequencing devices.
Dr Rose Wilson, of the Green lab, has written of their experience running a stall at the 'Science Uncovered' late-night event at the Natural History Museum, London.